Project Number 1R21AG051233-01 Agency/Funding Organization NIA Funding Year 2015 View Full Project Details for PRECLINICAL ASSESSMENT OF AN ABCA1 AGONIST AS A NOVEL THERAPEUTIC FOR AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) c. ApoE, Lipids and Lipoprotein Receptors Researcher and Organization Principal Investigator LADU, MARY JO Principal Investigator First Name MARY JO Principal Investigator Last Name LADU Awardee Organization UNIVERSITY OF ILLINOIS CHICAGO Awardee State Illinios Contact PI Country United States Project Detail Funding Opportunity Announcement PA-13-303: NIH Exploratory/Developmental Research Grant Program (Parent R21) FY Overall Cost $199,750 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
